The Role of Simvastatin in The Epithelial-Mesenchymal Transition Process of Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Chemotherapy Effect|Simvastatin Adverse Reaction
Interventions: DRUG: Simvastatin 40mg|DRUG: Placebo
Sponsor: Indonesia University